2014 | Medical Innovation Summit

Now, it's Personal

Cancer Treatment and Personalized Medicine October 27-29, 2014 Cleveland, Ohio

 
  • Download Our FREE Mobile App

    Stay connected. Download today!

    appleStore.pnggooglePlay.png
  • 2014 Summit Preview

    Join more than 1,500 senior executives, investors, entrepreneurs and clinicians who will gather in Cleveland to discuss investable innovations that can lead to the detection and treatment of cancer. The 2014 Summit will include:
     

    • Detailed insights into the latest breakthroughs of personalized medicine
    • Discussions with world leaders responsible for the change in healthcare technology.
    • Top 10 Medical Innovations for 2015
       

2013 Speakers

| View All Speakers

Lars Sørensen

CEO, Novo Nordisk

Lars Sørensen | CEO, Novo Nordisk ,

Gregory Sorensen, MD, is the President and Chief Executive Officer of Siemens Healthcare in North America, charged with leading the U.S. organization and providing additional oversight for Canada and Latin America.

As a trendsetter in medical imaging, therapy systems, laboratory diagnostics, and healthcare information technology, Siemens Healthcare offers optimized clinical solutions across the entire care continuum – from prevention and early detection to diagnosis, treatment and follow-up. By offering novel tools for improved diagnosis, as well as optimizing clinical workflows for the most common conditions, Siemens helps make healthcare faster, better and more cost-effective. As head of the business in the largest global market, Sorensen brings to his leadership position a deep understanding of technology, the biological basis of disease, the importance of measurable outcomes, and the environment of clinical practice. Sorensen was appointed to his current role in June 2011.

Previously, Sorensen served as Professor of Radiology and Health Sciences & Technology at Harvard Medical School; faculty member of the Harvard-MIT Division of Health Sciences and Technology; and Co-Director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, as well as a visiting professor of neuroradiology at Oxford University.

Leading up to his appointment with Siemens, Sorensen was a practicing neuroradiologist and active researcher with significant experience in clinical care, clinical trials, and translational research. His research and techniques are utilized by scores of centers throughout the world in phase II and III trials in cancer, stroke, and other illnesses.

Sorensen holds a BS in biology from California Institute of Technology, a MS in computer science from Brigham Young University, and a MD from Harvard Medical School. He is married with three children.

Peter Tippett, MD

Chief Medical Officer, Verizon Communications

Peter Tippett, MD | Chief Medical Officer, Verizon Communications ,

Dr. Tippett is Vice President of The Verizon Incubator and is Verizon’s Chief Medical Officer. He is responsible for Verizon’s healthcare strategy and the development of an extensive portfolio of solutions that enable the rapidly evolving healthcare information technology ecosystem.

Dr. Tippett has worked as an emergency room doctor and as a helicopter emergency physician and carries a California physician and surgeon license. His PhD work included the discovery and modelling of new regulatory mechanisms for glucose by the enzyme glucokinase. He worked for Nobel Laureates Robert Bruce Merrifield (chemistry, 1984) and Stanford Moore (chemistry, 1972) at Rockefeller University where Dr. Tippett was the first person to synthesize an active segment of an immunoglobulin. Earlier, he worked in the Charles Glueck laboratory in Cincinnati where he was one of the first individuals to research and consume “sucrose-octa-ester” (now called Olestra).

Dr. Tippett obtained a BS in biology from Kalamazoo College, and a MD and PhD in biochemistry from Case Western Reserve University. He is board certified in internal medicine.

William Winkenwerder, Jr., MD

CEO, Highmark, Inc.

William Winkenwerder, Jr., MD | CEO, Highmark, Inc. ,

Dr. Bill Winkenwerder is Chief Executive Officer and President of Highmark, a national diversified health and wellness company based in Pittsburgh, serving 34 million Americans.

Dr. Winkenwerder is one of the most influential and recognized leaders in American health care, and he is a prominent expert on the issues of national health policy and the economics of healthcare.

From 2001 to 2007, he was the Assistant Secretary of Defense for Health Affairs with responsibility for a $40 billion annual budget, 132,000 personnel and 9.2 million beneficiaries worldwide. Before that he served in senior leadership positions at Blue Cross of Massachusetts, Prudential Healthcare and Emory University. He also practiced primary care internal medicine.

Before joining Highmark, Dr. Winkenwerder served as Chairman and Chief Executive Officer of The Winkenwerder Company, a nationally respected healthcare consulting firm based in Alexandria, Virgina.

As a thought leader, Dr. Winkenwerder has been an advocate for preventive healthcare, evidenced-based medicine and electronic health records and has worked closely with many of America’s major employers on their health cost issues. He also brought many innovations and improved business practices to government during his tenure at the Department of Defense. Dr. Winkenwerder strongly advocates for engaging individuals and consumers in their healthcare and for improving public health. He has been an adviser to two presidential candidates and he has been a regular contributor to various news and media outlets.

A graduate of Davidson College and the University of North Carolina School of Medicine, Dr. Winkenwerder is board certified in internal medicine and received his MBA from the Wharton School at the University of Pennsylvania. Deeply committed to improving and reforming healthcare, he is a true visionary leader of one of the nation’s largest diversified health and wellness companies whose views are widely regarded.

Why Attend?

The Medical Innovation Summit provides an unrivaled perspective on the newest medical innovations and the financial drivers behind those innovations. The conference is recognized for providing singular insights, networking opportunities and actionable take away for all participants. The content is designed for:

  • Senior executives in the healthcare industry
  • Clinical, medical affairs, regulatory and business development executives
  • Venture capitalists and angel investor groups
  • Investment bankers
  • Buy-side and sell-side researchers
  • Consulting, legal and other service providers

Agenda Highlights

Monday | October 27th
  • New Ventures Healthcare Challenge
  • The State of Healthcare Innovation
  • Dinner and Keynote Address
Tuesday | October 28th
  • Live Surgery
  • The Business of Cancer Diagnostics
  • Imaging and Cancer Detection
  • Networking Recepton
Wednesday | October 29th
  • Therapeutics and Pharmaceuticals
  • Radiation
  • Revealing of the Top 10 Medical Innovations for 2015

2013 Sponsors

View All Past Sponsors

PREMIER
SPONSORS
PLATINUM
SPONSORS